Abstract.
Rationale: Prepulse inhibition (PPI) of the startle response in mice is increasingly used as a paradigm of sensory gating with potential predictive and construct validity towards schizophrenia. Objectives: Establishment of a mouse PPI paradigm in which typical and atypical antipsychotic drugs directly improve a low performance PPI. Methods: Three strains of mice – C57Bl/6J, 129S6/SvEvTac and DBA/2J – were tested in a startle paradigm with three prepulse intensities, 2, 4 and 8 dB above background. Results: Under these conditions, risperidone (0, 0.25, 0.5 and 1 mg/kg i.p.) and clozapine (0, 1, 3 and 9 mg/kg i.p.) improved PPI in all three strains, with order of effect in DBA/2J > 129S6SvEvTac > C57Bl/6J. The DBA/2J strain showed larger PPI-enhancing effects, without disturbing the basal startle response. Two α7 nicotinic receptor agonists, GTS-21 (1–10 mg/kg i.p.) and AR-R17779 (1–10 mg/kg i.p.) were inactive in the PPI procedure in DBA/2J mice. Conclusions: DBA/2J mice were very sensitive to the antipsychotic-like effects of atypical (clozapine) and typical (risperidone) antipsychotics, and this strain is proposed as a model to directly measure sensory gating properties of drugs. α7 Nicotinergic receptor agonists were ineffective in this PPI paradigm.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Electronic Publication
Rights and permissions
About this article
Cite this article
Olivier, B., Leahy, C., Mullen, T. et al. The DBA/2J strain and prepulse inhibition of startle: a model system to test antipsychotics?. Psychopharmacology 156, 284–290 (2001). https://doi.org/10.1007/s002130100828
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s002130100828